Regulatory22 May 2026, 11:34 am

Transchem Ltd Receives In-Principle Approval for Warrant Issue

AI Summary

Transchem Limited has received in-principle approval from BSE Limited for the preferential issue of 6,15,00,000 warrants, each with a face value of ₹10. The approval was granted via letter Ref: LOD/PREF/MV/FIP/266/2026-27 dated May 21, 2026, in accordance with Regulation 28 of the SEBI Listing Regulations. The company will now proceed with the necessary steps to complete the preferential issue.

Key Highlights

BSE grants in-principle approval for Transchem's warrant issue.
The preferential issue involves 6,15,00,000 warrants.
Each warrant has a face value of ₹10.
Approval is under Regulation 28 of SEBI Listing Regulations.
Transchem will initiate steps to consummate the preferential issue.

View BSE Filing

TRANSCHEM

Pharmaceuticals

TRANSCHEM LTD.-$

Price Impact